- Filed
- Jan 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 13, 2025 | 9.64M sh |
| Stock Repurchased | Q1 2025 · Nov 30, 2024 | $0 |
| Stock Repurchased | Q1 2025 · Nov 30, 2023 | $170.78K |
| Cash And Equivalents | Q1 2025 · Nov 30, 2024 | $1.53M |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $1.48M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $447.12K |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $522.93K |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $447.12K |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $522.93K |
| Current Assets | Q1 2025 · Nov 30, 2024 | $2.42M |
| Current Assets | Q1 2025 · Aug 31, 2024 | $2.37M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $3.63M |
| Total Assets | Q1 2025 · Aug 31, 2024 | $3.69M |
| Stock Issued | Q1 2025 · Nov 30, 2023 | 0 sh |
| Shares Diluted | Q1 2025 · Nov 30, 2023 | 10.29M sh |
| Capex | Q1 2025 · Nov 30, 2023 | $23.34K |
| Operating Cash Flow | Q1 2025 · Nov 30, 2023 | $188.77K |
| Stockholders Equity | Q1 2025 · Nov 30, 2023 | $3.55M |
| Stockholders Equity | Q1 2025 · Aug 31, 2023 | $3.47M |
| Eps Diluted | Q1 2025 · Nov 30, 2023 | $0.02 |
| Eps Basic | Q1 2025 · Nov 30, 2023 | $0.02 |
| Sga Expense | Q1 2025 · Nov 30, 2023 | $147.89K |
| Rd Expense | Q1 2025 · Nov 30, 2023 | $308.55K |
| Net Income | Q1 2025 · Nov 30, 2023 | $249.52K |
| Operating Income | Q1 2025 · Nov 30, 2023 | $237.99K |
| Gross Profit | Q1 2025 · Nov 30, 2023 | $991.38K |
| Cost Of Revenue | Q1 2025 · Nov 30, 2023 | $163.42K |
| Revenue | Q1 2025 · Nov 30, 2023 | $1.15M |